Wirtz, T.H.; Loosen, S.H.; Buendgens, L.; Kurt, B.; Abu Jhaisha, S.; Hohlstein, P.; Brozat, J.F.; Weiskirchen, R.; Luedde, T.; Tacke, F.;
et al. Low Myostatin Serum Levels Are Associated with Poor Outcome in Critically Ill Patients. Diagnostics 2020, 10, 574.
https://doi.org/10.3390/diagnostics10080574
AMA Style
Wirtz TH, Loosen SH, Buendgens L, Kurt B, Abu Jhaisha S, Hohlstein P, Brozat JF, Weiskirchen R, Luedde T, Tacke F,
et al. Low Myostatin Serum Levels Are Associated with Poor Outcome in Critically Ill Patients. Diagnostics. 2020; 10(8):574.
https://doi.org/10.3390/diagnostics10080574
Chicago/Turabian Style
Wirtz, Theresa H., Sven H. Loosen, Lukas Buendgens, Berkan Kurt, Samira Abu Jhaisha, Philipp Hohlstein, Jonathan F. Brozat, Ralf Weiskirchen, Tom Luedde, Frank Tacke,
and et al. 2020. "Low Myostatin Serum Levels Are Associated with Poor Outcome in Critically Ill Patients" Diagnostics 10, no. 8: 574.
https://doi.org/10.3390/diagnostics10080574
APA Style
Wirtz, T. H., Loosen, S. H., Buendgens, L., Kurt, B., Abu Jhaisha, S., Hohlstein, P., Brozat, J. F., Weiskirchen, R., Luedde, T., Tacke, F., Trautwein, C., Roderburg, C., & Koch, A.
(2020). Low Myostatin Serum Levels Are Associated with Poor Outcome in Critically Ill Patients. Diagnostics, 10(8), 574.
https://doi.org/10.3390/diagnostics10080574